Gritstone bio, Inc.
GRTSNASDAQHealthcare
$0.03
$-0.02(-31.78%)
Market Cap$3803110
P/E Ratio—
52W High$3.17
52W Low$0.03
Gritstone bio, Inc. (GRTS) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GRTS · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.33M | $9.27M | $46.72M | $4.04M | $4.37M |
| Cost of Revenue | $7.59M | $15.69M | $14.40M | $88.64M | $82.90M |
| Gross Profit | ($6.26M) | ($6.42M) | $32.32M | ($84.61M) | ($78.53M) |
| Gross Margin %(computed) | -470.32% | -69.28% | 69.18% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $127.18M | $111.40M | $97.49M | $88.64M | $82.90M |
| G&A Expenses | $28.78M | $28.97M | $25.93M | $21.41M | $19.41M |
| Total Operating Expenses | $148.37M | $129.70M | $121.93M | $110.05M | $102.31M |
| Operating Income | ($154.63M) | ($120.43M) | ($75.21M) | ($106.02M) | ($97.94M) |
| Operating Margin %(computed) | — | — | -160.99% | — | — |
| Interest Income | $5.20M | $1.98M | $0.16M | $0.71M | $3.51M |
| Interest Expense | $4.04M | $1.24M | $0.04M | $0.01M | $0.00M |
| Income Before Tax | ($138.49M) | ($119.69M) | ($75.08M) | ($105.31M) | ($94.43M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($138.49M) | ($113.13M) | ($74.95M) | ($104.61M) | ($90.93M) |
| Net Margin %(computed) | — | — | -160.44% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.20 | $-1.24 | $-0.95 | $-2.77 | $-2.71 |
| Wtd Avg Shares | 115.53M | 90.92M | 78.89M | 37.79M | 33.55M |
| EBITDA | ($126.86M) | ($111.89M) | ($68.70M) | ($98.67M) | ($93.19M) |
| EBITDA Margin %(computed) | — | — | -147.05% | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Gritstone bio, Inc. data
About Gritstone bio, Inc. (GRTS) Income Statement
Gritstone bio, Inc. (GRTS) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, GRTS reported revenue of $0.00B, gross profit of ($0.01B) (gross margin -470.32%), and net income of ($0.14B) — a net profit margin of -10404.96%.
Frequently asked questions
GRTS · 4 questionsGritstone bio, Inc. (GRTS) reported revenue of $0.00B for 2023, down 85.6% year-over-year.
GRTS revenueGRTS salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09